Resource Logo
NLM AIDSLINE

HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia.




 

Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):26-9. Unique

A serological investigation for human T cell leukemia virus I (HTLV-I) infection was carried out at the University Hospital, Kuala Lumpur. A total of 626 sera from a non-patient population and 1,038 sera from unselected in-patients were screened for HTLV-I antibodies using an enzyme-linked immunosorbent assay (ELISA). 27/1664 (1.6%) were found to be reactive. However, on Western blotting, only 2 sera were confirmed positive, both showing reactions for the major core (p19 and p24) and the envelope (gp46) proteins. Both of the serum samples were from unselected hospital patients. Most of the remaining sera which were reactive on screening showed indeterminate results on Western blotting. These were further tested by radioimmunoprecipitation assay (RIPA) and none of these sera gave a positive reaction. Therefore, only 2/1038 (0.19%) unselected patients could be confirmed to have antibodies to HTLV-I. None of the normal individuals screened showed a positive Western blot result. Our data indicate that HTLV-I infection is present in our population, but at a low prevalence rate.

Adult Blotting, Western/STANDARDS Enzyme-Linked Immunosorbent Assay/STANDARDS Ethnic Groups Hospitals, University Human HTLV-BLV Antigens/BLOOD HTLV-I Antibodies/*BLOOD HTLV-I Infections/BLOOD/*EPIDEMIOLOGY/IMMUNOLOGY Malaysia/EPIDEMIOLOGY Male Mass Screening Prevalence Radioimmunoprecipitation Assay/STANDARDS Sensitivity and Specificity Seroepidemiologic Methods Support, Non-U.S. Gov't JOURNAL ARTICLE



 




Information in this article was accurate in December 30, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.